Reaction
Renal Tubular Dysfunction reporting signals
As of the last recalculation, Renal Tubular Dysfunction appears in 551 FAERS reports alongside 19 co-occurring drug terms. The strongest observed disproportionality signal is TENOFOVIR DISOPROXIL FUMARATE TABLETS (PRR 356.4).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Tenofovir Disoproxil Fumarate Tablets | 71 | 356.4 | 359.4 |
| Tenofovir Disoproxil Fumarate | 110 | 156.8 | 157.3 |
| Lamivudine Oral | 56 | 93.0 | 93.2 |
| Ritonavir 100 Mg | 34 | 91.6 | 91.8 |
| Lamivudine | 60 | 82.2 | 82.4 |
| Atazanavir | 25 | 68.8 | 68.9 |
| Abacavir Sulfate | 17 | 68.0 | 68.1 |
| Efavirenz | 17 | 59.4 | 59.5 |
| Darunavir | 22 | 57.2 | 57.3 |
| Ritonavir | 41 | 57.2 | 57.3 |
| Raltegravir | 22 | 52.4 | 52.5 |
| Elvitegravir, Cobicistat, Emtricitabine, And Tenofovir Alafenamide | 9 | 34.3 | 34.4 |
| Emtricitabine And Tenofovir Disoproxil Fumarate | 34 | 29.9 | 30.0 |
| Elvitegravir, Cobicistat, Emtricitabine, And Tenofovir Disoproxil Fumarate | 7 | 29.7 | 29.8 |
| Bictegravir Sodium, Emtricitabine, And Tenofovir Alafenamide Fumarate | 13 | 27.7 | 27.7 |
| Emtricitabine And Tenofovir Alafenamide | 8 | 27.0 | 27.0 |
| Ifosfamide | 13 | 23.4 | 23.4 |
| Dolutegravir Sodium | 5 | 21.1 | 21.1 |
| Sofosbuvir | 9 | 17.5 | 17.5 |